Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019

Health Senate 12 cosponsors

Latest action: Read twice and referred to the Committee on Finance. · February 13, 2019

Understand the measure

What this bill does

No official summary is on file here yet. Check Congress.gov for available summaries and the bill text.

Check official summaries ↗

The measure

The official bill title and text published by Congress and GovInfo.

The movement

Every committee, chamber, and clerk-recorded action attached to its date.

The votes

Every roll call on this measure—or a clear notice when no individual vote exists.

Where it stands

The measure's progress

In committee

Read twice and referred to the Committee on Finance.

Recorded February 13, 2019, as the clerk wrote it

Sponsor Sen. Wyden, Ron [D-OR]

Committee Finance Committee

Recorded votes None taken

The official record

Congress.gov bill page
The bill text, as published by GPO GovInfo
Article I, Section 7 of the Constitution: how a bill becomes law
Status, sponsor and actions from the official GovInfo record, read October 12, 2026 · see sources

Cite this record

Reference number: bill-116-s474
Permanent link: https://votefiles.com/cite/bill-116-s474
Official source: Congress.gov ↗
Last checked: October 12, 2026Status and actions last read from the official GovInfo BILLSTATUS record

AP style

Vote Files, "S. 474 (116th Congress): Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019," last checked Oct. 12, 2026, citing Congress.gov, https://votefiles.com/cite/bill-116-s474

APA

Vote Files. (2026, October 12). S. 474 (116th Congress): Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 [Bill record]. Retrieved October 14, 2026, from https://votefiles.com/cite/bill-116-s474

Chicago

Vote Files. "S. 474 (116th Congress): Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019." Last modified October 12, 2026. Accessed October 14, 2026. https://votefiles.com/cite/bill-116-s474.

BibTeX

@misc{votefiles_bill_116_s474,
  author       = {{Vote Files}},
  title        = {{S. 474 (116th Congress): Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019}},
  year         = {2026},
  howpublished = {\url{https://votefiles.com/cite/bill-116-s474}},
  note         = {Reference number bill-116-s474; official source: Congress.gov, https://www.congress.gov/bill/116th-congress/senate-bill/474; last checked October 12, 2026; accessed October 14, 2026}
}

Plain link

https://votefiles.com/cite/bill-116-s474

Cite the official source for the underlying fact. The Vote Files reference number never changes for this record. AP, APA and Chicago are standard citation styles for news and academic writing, and BibTeX is the format reference-manager programs read.

Official analyses

CBO cost estimates and CRS reports on S. 474

Published March 31, 2021Drug Pricing and Intellectual Property: The Legislative Landscape for the 117th Congress (PDF)
CRS · Reports · R46741

Listed only where the Congressional Budget Office names this bill number in its estimate's title and that title matches the bill's own, or where the Congressional Research Service lists this bill among a report's related materials. Titles and dates are the publishers' own. All watchdog and scorekeeper reports

On the record

No recorded vote

No roll call has been taken on this measure, so no member's position on it is on the record. Most measures never get one.